Number of COPD Cases Expected to Increase Through 2030

Share this content:
Number of COPD Cases Expected to Increase Through 2030
Number of COPD Cases Expected to Increase Through 2030

TUESDAY, Sept. 27, 2016 (HealthDay News) -- The number of chronic obstructive pulmonary disease (COPD) cases is expected to increase through 2030, with the greatest increase anticipated for those aged 75 years and older, according to research published online Sept. 4 in the American Journal of Respiratory and Critical Care Medicine.

Amir Khakban, from the University of British Columbia in Vancouver, Canada, and colleagues used data from British Columbia to illustrate the projected growth of COPD hospitalizations over the next 15 years in developed countries. Forecasts of population growth and aging were combined with an Autoregressive Integrated Moving Average model applied to population-based administrative health databases for 2001 to 2010 for British Columbia.

The researchers predict that the absolute number of COPD cases will increase by more than 150 percent from 2010 to 2030, with the greatest increase among those aged 75 years and older (projected increase of 220 percent). They anticipate a 185 percent increase in the burden of inpatient care, measured as the total annual inpatient days.

"Assuming no disruptive changes in the prevention and the treatment of COPD in the near future, the burden of COPD, especially the burden of inpatient care, will significantly escalate over the next 15 years, driven predominantly by population aging," the authors write. "There is a pressing need to develop new preventive strategies and treatments to reduce the future burden of COPD."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »